---
figid: PMC5344005__ijms-18-00473-g001
figtitle: Molecular functions of long non-coding RNAs (lncRNAs) at different stages
  of prostate cancer, from prostate adenocarcinoma (A) to ongoing castration resistance
  (B) to a castration-resistant state (C)
organisms:
- Homo sapiens
- Mus musculus
pmcid: PMC5344005
filename: ijms-18-00473-g001.jpg
figlink: /pmc/articles/PMC5344005/figure/ijms-18-00473-f001/
number: F1
caption: 'Molecular functions of long non-coding RNAs (lncRNAs) at different stages
  of prostate cancer, from prostate adenocarcinoma (A) to ongoing castration resistance
  (B) to a castration-resistant state (C). Dashed squares signify reduced or downregulated
  proteins/lncRNAs or genes, whilst solid boxes indicate overexpressed or upregulated
  proteins/lncRNAs or genes. Solid lines signify an active pathway, and dashed lines
  an inactive pathway. LncRNAs are framed by red, angular shaped boxes. Genes and
  proteins are framed by white boxes with blunt edges. DANCR: differentiation antagonising
  non-protein coding RNA; MEG3: lncRNA Maternally expressed gene 3; PCA3: prostate
  cancer antigen 3; DRAIC: Downregulated RNA in cancer; PCAT29: Prostate cancer-associated
  transcript 29; GAS5: growth arrest-specific 5; CTBP1-AS: C-terminal binding protein
  1-antisense; PCGEM: prostate cancer gene expression marker 1; MALAT-1: metastasis-associated
  lung adenocarcinoma transcript-1; NEAT1: nuclear-enriched abundant transcript 1;
  PCAT5: prostate cancer-associated transcript 5; SChLAP1: Second chromosome locus
  associated with prostate-1; HOTAIR: HOX transcript antisense RNA; SOCS2-AS1: cytokine
  signalling 2-antisense transcript 1; TIMP 2/3: tissue inhibitor of metalloproteinase;
  EZH2: enhancer of zeste homolog; ZNF217: zink finger protein 217; ZEB1: zinc-finger
  E-box binding homeobox 1; PRUNE2: prune homolog 2; NKX3-1: homeobox protein Nkx-3.1;
  FOXA1: Forkhead box protein A1; BCL4: B-cell lymphoma like-2 like protein 4; SMAD3:
  Mothers against decapentaplegic homolog 3; CTBP1: C-terminal binding protein 1-antisense;
  HDAC-Sin3A: histone decarboxylase paired amphipathic helix protein Sin3a complex;
  TMEM48: transmembrane Protein 48; CKS2: cyclin-dependent kinases regulatory subunit
  2; hnRNP A1: heterogeneous nuclear ribonucleoprotein A1; U2AF65: U2 Small Nuclear
  RNA Auxillary Factor 2; DAB2IP: disabled homolog 2-interacting protein; TMPRSS2:
  transmembrane Protease, Serine 2; ERG: ETS-(E-twenty-six) related gene; SWI/SFN
  complex: SWItch/Sucrose Non-Fermentable complex; TNSF10: tumour necrosis factor
  superfamily member 10; MDM2: mouse double minute 2 homolog.'
papertitle: Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer.
reftext: Maria A. Smolle, et al. Int J Mol Sci. 2017 Feb;18(2):473.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9316991
figid_alias: PMC5344005__F1
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
redirect_from: /figures/PMC5344005__F1
ndex: 42569925-df0a-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5344005__ijms-18-00473-g001.html
  '@type': Dataset
  description: 'Molecular functions of long non-coding RNAs (lncRNAs) at different
    stages of prostate cancer, from prostate adenocarcinoma (A) to ongoing castration
    resistance (B) to a castration-resistant state (C). Dashed squares signify reduced
    or downregulated proteins/lncRNAs or genes, whilst solid boxes indicate overexpressed
    or upregulated proteins/lncRNAs or genes. Solid lines signify an active pathway,
    and dashed lines an inactive pathway. LncRNAs are framed by red, angular shaped
    boxes. Genes and proteins are framed by white boxes with blunt edges. DANCR: differentiation
    antagonising non-protein coding RNA; MEG3: lncRNA Maternally expressed gene 3;
    PCA3: prostate cancer antigen 3; DRAIC: Downregulated RNA in cancer; PCAT29: Prostate
    cancer-associated transcript 29; GAS5: growth arrest-specific 5; CTBP1-AS: C-terminal
    binding protein 1-antisense; PCGEM: prostate cancer gene expression marker 1;
    MALAT-1: metastasis-associated lung adenocarcinoma transcript-1; NEAT1: nuclear-enriched
    abundant transcript 1; PCAT5: prostate cancer-associated transcript 5; SChLAP1:
    Second chromosome locus associated with prostate-1; HOTAIR: HOX transcript antisense
    RNA; SOCS2-AS1: cytokine signalling 2-antisense transcript 1; TIMP 2/3: tissue
    inhibitor of metalloproteinase; EZH2: enhancer of zeste homolog; ZNF217: zink
    finger protein 217; ZEB1: zinc-finger E-box binding homeobox 1; PRUNE2: prune
    homolog 2; NKX3-1: homeobox protein Nkx-3.1; FOXA1: Forkhead box protein A1; BCL4:
    B-cell lymphoma like-2 like protein 4; SMAD3: Mothers against decapentaplegic
    homolog 3; CTBP1: C-terminal binding protein 1-antisense; HDAC-Sin3A: histone
    decarboxylase paired amphipathic helix protein Sin3a complex; TMEM48: transmembrane
    Protein 48; CKS2: cyclin-dependent kinases regulatory subunit 2; hnRNP A1: heterogeneous
    nuclear ribonucleoprotein A1; U2AF65: U2 Small Nuclear RNA Auxillary Factor 2;
    DAB2IP: disabled homolog 2-interacting protein; TMPRSS2: transmembrane Protease,
    Serine 2; ERG: ETS-(E-twenty-six) related gene; SWI/SFN complex: SWItch/Sucrose
    Non-Fermentable complex; TNSF10: tumour necrosis factor superfamily member 10;
    MDM2: mouse double minute 2 homolog.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ITK
  - SLC22A3
  - HDAC9
  - HDAC1
  - HDAC2
  - HDAC3
  - HDAC8
  - HDAC4
  - HDAC5
  - HDAC7
  - HDAC6
  - HDAC10
  - SIRT1
  - SIRT2
  - SIRT3
  - SIRT4
  - SIRT5
  - SIRT6
  - SIRT7
  - HDAC11
  - TNC
  - TNN
  - TNR
  - TNXB
  - ERG
  - BTNL2
  - EZH2
  - CKS2
  - PC
  - PCAT5
  - SMAD3
  - SFN
  - REXO2
  - CTBP1-AS
  - PSMC3
  - TBP
  - TNFRSF1A
  - EGFLAM-AS3
  - PHEX
  - TP53
  - TP63
  - TP73
  - .na.character
  - H3-4
  - H3-5
  - H1-0
  - H1-1
  - H1-2
  - H1-3
  - H1-4
  - H1-5
  - H1-6
  - H1-7
  - H1-8
  - H1-10
  - H2AB1
  - H2AJ
  - H2AZ2
  - H2AX
  - MACROH2A1
  - MACROH2A2
  - H2AZ1
  - H2AC1
  - H2AC6
  - H2AC7
  - H2AC12
  - H2AC14
  - H2AC21
  - H2AC20
  - H2AC25
  - H2BC1
  - H2BC3
  - H2BC5
  - H2BC9
  - H2BC11
  - H2BC12
  - H2BC13
  - H2BC14
  - H2BC15
  - H2BC17
  - H2BC18
  - H2BC19P
  - H2BC20P
  - H2BC21
  - H2BC26
  - H2BC12L
  - H2BW2
  - H2BW1
  - H4C7
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - U2AF2
  - AR
  - DANCR
  - CGA
  - LHB
  - IH
  - MEG3
  - NIBAN2
  - BCL3
  - ZNF217
  - LNCRNA-ATB
  - TH
  - MDM2
  - SLURP1
  - PCA3
  - PRUNE2
  - ELAVL4
  - PCAT29
  - RORC
  - Itk
  - Slc22a3
  - Erg
  - pr
  - Ezh2
  - sc
  - Cks2
  - pc
  - Smad3
  - Sfn
  - Rexo2
  - Psmc3
  - Phex
  - Kitl
  - Trp53
  - H3
  - Casp3
  - Ar
  - Dancr
  - Meg3
  - Niban2
  - Zfp217
  - Th
  - Mdm2
  - Ttn
  - Enpp1
  - Prune2
  - Elavl4
  - tor
  - Rorc
  - Pat
  - Enzalutamide
  - Androgen
---
